Qiagen

Yahoo Finance • 6 months ago

QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system

QIAstat-Dx Analyzer 2.0 with Software 1.6 release enables mobile access to test results, streamlining diagnostic processes and enhancing patient care // QIAstat-Dx Analyzer 2.0 also offers enhanced epidemiology dashboards and improved remo... Full story

Yahoo Finance • 7 months ago

Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript

Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript February 11, 2024 Qiagen N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. I'm Melinda, you... Full story

Yahoo Finance • 7 months ago

The Qiagen N.V. (NYSE:QGEN) Full-Year Results Are Out And Analysts Have Published New Forecasts

Last week saw the newest yearly earnings release from Qiagen N.V. (NYSE:QGEN), an important milestone in the company's journey to build a stronger business. Revenues of US$2.0b were in line with forecasts, although statutory earnings per s... Full story

Yahoo Finance • 8 months ago

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

NeuMoDx CT/NG Assay designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the U.S. // U.S. regulatory clearance of new assay for use on both NeuMoDx 96 and 288 versions of integr... Full story

Yahoo Finance • 9 months ago

QIAGEN expands business in Middle East with new regional headquarters and major projects

QIAGEN to open regional headquarters in Riyadh, Saudi Arabia, at the beginning of 2024 to support growing presence in the region // QIAGEN signed Memorandum of Understanding with the Ministry of Health of Saudi Arabia to support public hea... Full story

Yahoo Finance • 11 months ago

QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System

Venlo, the Netherlands, and San Diego, California, Nov. 02, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Element Biosciences, Inc. today announced a strategic partnership to offer comprehensive next-gen... Full story

Yahoo Finance • 11 months ago

Partnerschaft zwischen QIAGEN und Element Biosciences ermöglicht vollständige NGS-Workflows für das AVITI-System

Partnerschaft unterstützt Nutzer des AVITI-Systems von Element bei der Genomanalyse mit QIAseq Panels, CLC LightSpeed und QCI Interpret von QIAGEN // Zusammenarbeit beschleunigt wissenschaftliche Entdeckungen bei Genomanwendungen, macht si... Full story

Yahoo Finance • 11 months ago

QIAGEN und Myriad Genetics schließen Partnerschaft und treiben Entwicklung von Begleitdiagnostika für Krebs voran

Partnerschaft umfasst die Entwicklung von im Labor entwickelten (LDT) und vertriebsfähigen diagnostischen Begleittests auf Kit-Basis // Vereinte Stärken in den Bereichen Assay-Entwicklung, klinische Tests und regulatorische Zulassungen bie... Full story

Yahoo Finance • 11 months ago

QIAGEN N.V. to release results for Q3 2023 and hold webcast

Venlo, the Netherlands, Oct. 09, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the third quarter 2023. Press release date / time: Monday, October 30, shortly... Full story

Yahoo Finance • last year

QIAGEN provides reminder on settlement mechanics of 2023 and 2024 convertible notes

Venlo, the Netherlands, June 16, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a notice (reiterating its notice to holders dated January 9, 2019) to holders of the following: - 0.500% Sen... Full story

Yahoo Finance • last year

Nationales Genomzentrum Dänemark entscheidet sich für QIAGEN-Lösung zur Genomsequenzierung in der Onkologie

Als eines der ersten Länder führt Dänemark die Gesamtgenomsequenzierung als Therapiestandard bei onkologischen Erkrankungen ein und nutzt QCI Interpret für nationale Initiative // QCI Interpret soll zur evidenzbasierten Interpretation und... Full story

Yahoo Finance • last year

Danish National Genome Center selects QIAGEN for variant interpretation in oncology genome sequencing

Venlo, the Netherlands, and Redwood City, California, June 13, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its variant interpretation and reporting software, QIAGEN Clinical Insight (Q... Full story

Yahoo Finance • last year

QIAGEN N.V. to release results for Q1 2023 and hold webcast

Venlo, The Netherlands, April 18, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the first quarter 2023. Press release date / time: Wednesday, May 3, shortly... Full story

Yahoo Finance • last year

QIAGENs QIAxcel Connect gewinnt Red Dot Design Award

VENLO, Niederlande, March 29, 2023 (GLOBE NEWSWIRE) -- Das hochauflösende Gelelektrophorese-Gerät für DNA- oder RNA-Proben QIAxcel Connect von QIAGEN wurde mit dem renommierten Red Dot Award ausgezeichnet. Es ist bereits das vierte Gerät... Full story

Yahoo Finance • last year

QIAGEN’s QIAxcel Connect wins Red Dot design award

Venlo, the Netherlands, March 29, 2023 (GLOBE NEWSWIRE) -- QIAGEN today announced that QIAxcel Connect, its high-resolution gel electrophoresis instrument for use with DNA or RNA samples, has won the prestigious Red Dot award. This marks... Full story

Yahoo Finance • 2 years ago

Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely

A rumored matchup between Bio-Rad Laboratories and Qiagen is unlikely, an analyst said Tuesday as BIO stock fell for a second straight day. Continue reading... Full story

Yahoo Finance • 2 years ago

Biotech Firms Bio-Rad and Qiagen Discuss Major Merger

It's the circle of life for life-sciences companies. The California-based Bio-Rad Laboratories and the Netherlands-based Qiagen are deep in talks... Continue reading... Full story

Yahoo Finance • 2 years ago

East Bay life sciences company reportedly in talks with Qiagen in $10 billion deal

The company was started in Berkeley in the early 1950s, growing to nearly 8,000 employees worldwide. Continue reading... Full story

Yahoo Finance • 2 years ago

QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook

Q2 2022: Net sales of $516 million (-9% actual rates, -4% CER); diluted EPS of $0.42 and adjusted diluted EPS of $0.51 over year-ago period Net sales of $544 million at CER vs. outlook for at least $510 million CER, adjusted diluted EPS o... Full story